Comerica Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-679
Closed -$141K 1202
2022
Q4
$141K Buy
+679
New +$149K 0.01% 533
2022
Q2
Sell
-865
Closed -$210K 503
2022
Q1
$210K Buy
865
+12
+1% +$2.9K 0.01% 470
2021
Q4
$222K Sell
853
-72
-8% -$18.7K 0.01% 471
2021
Q3
$244K Sell
925
-20
-2% -$5.47K 0.02% 456
2021
Q2
$233K Sell
945
-1,908
-67% -$401K 0.02% 445
2021
Q1
$554K Sell
2,853
-6
-0.2% -$1.2K 0.04% 299
2020
Q4
$608K Buy
2,859
+17
+0.6% +$3.39K 0.05% 267
2020
Q3
$487K Sell
2,842
-3
-0.1% -$554 0.04% 280
2020
Q2
$546K Sell
2,845
-301
-10% -$49.2K 0.05% 255
2020
Q1
$463K Sell
3,146
-48
-2% -$7.64K 0.05% 254
2019
Q4
$495K Sell
3,194
-5
-0.2% -$721 0.05% 286
2019
Q3
$432K Sell
3,199
-266
-8% -$34.9K 0.04% 293
2019
Q2
$423K Buy
3,465
+782
+29% +$86.6K 0.05% 295
2019
Q1
$279K Buy
+2,683
New +$277K 0.03% 356

Other funds holding RMD

Comerica Securities's RMD Position: Q1 2023 in Review

Comerica Securities sold out of ResMed (RMD) in Q1 2023, closing a stake of 679 shares — an estimated $141K sold.

Comerica Securities first reported a position in RMD in Q1 2019 and held it in 14 quarters. The position peaked at $608K in Q4 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Comerica Securities reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 679 ResMed shares in Q1 2023, an estimated $141K.
  • Comerica Securities first reported a position in ResMed in Q1 2019 and held it in 14 quarters.
  • Comerica Securities's ResMed position peaked at $608K in Q4 2020.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.